February 23, 2024 • 00:06:04

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Randomized, Vehicle- Controlled, Multicenter, Phase 3 Trial (Saturn-2) Hosted by: Andrew Pucker, OD, PhD, FAAO Topical Editor: Andrew Pucker, OD, PhD, FAAO Topical Expert: Patrick Vollmer, OD, FAAO - Tarsus Article: https://pubmed.ncbi.nlm.nih.gov/37285925/

No transcript available.